MFN Partners Management, LP - Q3 2020 holdings

$1.22 Billion is the total value of MFN Partners Management, LP's 16 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 100.0% .

 Value Shares↓ Weighting
CLGX BuyCORELOGIC INC$203,010,000
+151.7%
3,000,000
+150.0%
16.60%
+47.6%
WPF NewFOLEY TRASIMENE ACQUISTN COR$145,040,00014,000,000
+100.0%
11.86%
LNG  CHENIERE ENERGY INC$131,956,000
-4.2%
2,851,8600.0%10.79%
-43.8%
LBTYK  LIBERTY GLOBAL PLC$127,450,000
-4.5%
6,206,4600.0%10.42%
-44.0%
BFTU NewFOLEY TRASIMENE ACQUISITIONunit 99/99/9999$102,000,00010,000,000
+100.0%
8.34%
XPO  XPO LOGISTICS INC$98,157,000
+9.6%
1,159,4260.0%8.02%
-35.7%
HCA  HCA HEALTHCARE INC$70,444,000
+28.5%
565,0000.0%5.76%
-24.7%
BABA NewALIBABA GROUP HLDG LTDsponsored ads$58,796,000200,000
+100.0%
4.81%
WFC NewWELLS FARGO CO NEW$56,424,0002,400,000
+100.0%
4.61%
MYL BuyMYLAN NV$55,613,000
+25.8%
3,750,000
+36.4%
4.55%
-26.2%
FB NewFACEBOOK INCcl a$51,856,000198,000
+100.0%
4.24%
GOOG NewALPHABET INCcap stk cl c$44,088,00030,000
+100.0%
3.60%
FNF  FIDELITY NATIONAL FINANCIAL$43,834,000
+2.1%
1,400,0000.0%3.58%
-40.1%
CYCN  CYCLERION THERAPEUTICS INC$14,760,000
+2.9%
2,427,6770.0%1.21%
-39.6%
WPFWS NewFOLEY TRASIMENE ACQUISTN COR*w exp 05/26/202$10,547,0004,666,745
+100.0%
0.86%
OXYWS NewOCCIDENTAL PETE CORP*w exp 08/03/202$9,308,0003,102,790
+100.0%
0.76%
ACRS ExitACLARIS THERAPEUTICS INC$0-3,338,718
-100.0%
-0.75%
EOLS ExitEVOLUS INC$0-1,420,000
-100.0%
-1.05%
WPFU ExitFOLEY TRASIMENE ACQUISTN CORunit 99/99/9999$0-10,000,000
-100.0%
-14.87%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-11-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
XPO LOGISTICS INC20Q3 202331.8%
LIBERTY GLOBAL PLC- C18Q3 202318.6%
CYCLERION THERAPEUTICS INC16Q1 20232.7%
HCA HEALTHCARE INC15Q3 202310.9%
CHENIERE ENERGY INC13Q4 202119.2%
OCCIDENTAL PETROLEUM CORP13Q3 202310.5%
PENNYMAC FINL SVCS INC NEW11Q3 202312.2%
ALPHABET INC-CL A9Q2 202312.9%
LITHIA MTRS INC8Q3 202316.0%
META PLATFORMS INC7Q4 202114.1%

View MFN Partners Management, LP's complete holdings history.

Latest significant ownerships (13-D/G)
MFN Partners Management, LP Q3 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Foley Trasimene Acquisition Corp.March 15, 20215,000,0004.8%
Cyclerion Therapeutics, Inc.February 12, 20212,427,6777.2%
Foley Trasimene Acquisition Corp.February 12, 202114,000,00013.5%
Foley Trasimene Acquisition IISold outFebruary 12, 202100.0%
Aclaris Therapeutics, Inc.July 22, 20201,895,6774.5%

View MFN Partners Management, LP's complete significant-ownership history.

Latest filings
TypeFiled
42024-04-26
42024-04-24
42024-04-19
42024-04-17
13F-HR2024-02-13
42024-02-12
42024-02-06
42023-11-24
42023-11-20
42023-11-15

View MFN Partners Management, LP's complete filings history.

Compare quarters

Export MFN Partners Management, LP's holdings